Age related macular degeneration

British Medical Journal

Volumn 333, Issue 7574, 2006, Pages 869-870

  Chakravarthy, Usha ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; ELDERLY CARE; EUROPE; HEALTH STATUS; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; SHORT FORM 36; SOCIAL PSYCHOLOGY; UNITED KINGDOM; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

HEALTH STATUS; HUMANS; MACULAR DEGENERATION; QUALITY OF LIFE; QUESTIONNAIRES; VISION DISORDERS;

EID: 33750589750     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39009.366736.80     Document Type: Editorial

References (10)

1. Augood C, Vingerling J, deJong PT, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of age-related maculopathy in older Europeans: the European eye study (EUREYE). Arch Ophthalmol 2006;123:529-35.
2. Evans JR, Fletcher AK, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council trial of assessment and management of older people in the community. Ophthalmology 2005;111:513-7.
3. Slakter JS, Stur M. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophthalmol 2005;50:263-73.
4. Mitchell J, Bradley C. Quality of life in age-related macular degeneration. A review of the literature. http://amdalliance.org/documents/ White%20paper%20amended%20final%20fcr%201909061.pdf (accessed 19 Oct 2006).
5. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001;357:7-8.
6. Mangionce CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al. Identifying the content area for the 51-item National Eye Institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 1998;116:227-33.
7. Mitchell J, Bradley C. Design of an individualised measure of the impact of macular disease on quality of life: the MacDQoL. Qual Life Res 2004;13:1163-75.
8. Fletcher DC, Schuchard RA. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity. Optom Vis Sci 2006;83:178-89.
9. Hogg RE, Curry E, Muldrew A, Winder J, Stevenson M, McClure M, et al. Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol 2003;87:609-14.
10. Stone EM. A very effective treatment for neovascular macular degeneration. N Engl J Med 2006;355:1493-5.